Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A failed noncomplicity scheme.

Louis M Guenin1

  • 1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA. guenin@harvard.edu

Stem Cells and Development
|December 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wishful thinking will not obviate embryo use.

Stem cell reviews·2006
Same author

A proposed stem cell research policy.

Stem cells (Dayton, Ohio)·2005
Same author

On classifying the developing organism.

Connecticut law review·2005
Same author

Stem cells, cloning, and regulation.

Mayo Clinic proceedings·2005
Same author

Stem cells: shibboleths of development.

Stem cells and development·2005
Same author

The morality of unenabled embryo use--arguments that work and arguments that don't.

Mayo Clinic proceedings·2004
Same journal

Inflammatory Preconditioning Reprograms Mesenchymal Stromal Cell-Derived Extracellular Vesicles into Distinct Functional States for Immunomodulation and Wound Healing.

Stem cells and development·2026
Same journal

Cancer Stem Cells as Dynamic Attractor States: Systems Biology of Tumor Plasticity and Therapy Resistance.

Stem cells and development·2026
Same journal

Evaluation of Puromycin-Induced Podocyte Injury and Protective Effects of Voclosporin Using Induced Pluripotent Stem Cells from a Patient with Nephrotic Syndrome Harboring an <i>INF2</i> Variant.

Stem cells and development·2026
Same journal

Simplified Derivation of Stable Early Passage Murine Embryonic and Parthenogenetic Stem Cells.

Stem cells and development·2026
Same journal

OCT3/4-Enhanced Dental Mesenchymal Stem Cells Acquire Hematopoietic Stem Cell-Like Properties and Support Hematopoietic Recovery in a Myelosuppressed Mouse Model.

Stem cells and development·2026
Same journal

Hematopoietic Stem Cell-Based Cell and Gene Therapy Beyond Monogenic Diseases.

Stem cells and development·2026
See all related articles

US policy on embryonic stem cell research funding is flawed. It wrongly assumes government funding didn't induce prior stem cell line creation, thus failing morally and hindering scientific progress.

Area of Science:

  • Bioethics
  • Stem Cell Research Policy

Background:

  • Current U.S. policy on embryonic stem cell research funding is based on the August 9, 2001 announcement.
  • This policy assumes no prior inducement by the government for the creation of stem cell lines before this date.
  • It suggests government funding is permissible for pre-existing lines without complicity in embryo destruction.

Purpose of the Study:

  • To critically evaluate the U.S. policy on funding embryonic stem cell research.
  • To examine the premise of non-inducement for stem cell lines created before August 9, 2001.
  • To assess the policy's ethical standing and impact on scientific advancement.

Main Methods:

  • Analysis of the U.S. policy's foundational assumptions regarding government inducement.
  • Historical review of stem cell line creation in relation to policy announcements.
Keywords:
Biomedical and Behavioral ResearchGenetics and Reproduction

Related Experiment Videos

  • Ethical and logical examination of the policy's justification and implications.

    • Main Results:

    • The policy's escape from complicity in embryo destruction is illusory.
    • Historical facts contradict the supposition that government did not induce prior stem cell line creation.
    • Adjusting the eligible creation date would undermine the policy's justification.

    Conclusions:

    • The U.S. policy on embryonic stem cell research funding is morally unavailing.
    • The policy significantly constrains scientific progress in the field.
    • The policy's justification is based on a flawed premise regarding government inducement.